This page contains a Flash digital edition of a book.
NEWS REVIEW Merck KGaA to acquire Sigma-Aldrich


MERCK KGaA and Sigma-Aldrich have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.


Merck KGaA, Darmstadt, Germany, will acquire all of the outstanding shares of Sigma-Aldrich for $140 per share in cash. The agreed price represents a 37 percent premium to the latest closing price of $102.37 on September 19, 2014, and a 36 percent premium to the one-month average closing price. The transaction is expected to be immediately accretive to Merck KGaA,


“This transaction marks a milestone on our transformation journey aimed at turning our three businesses into sustainable growth platforms”, said Karl- Ludwig Kley, Chairman of Merck KGaA, Darmstadt, Germany’s Executive Board. “For our life science business it’s even more than that: it’s a quantum leap.


“In one of the world’s key industries two companies that fit perfectly together have found each other to present a much broader product offering to our global customers in research, pharma and biopharma manufacturing and diagnostic and testing labs. As such, the


Aldrich into a customer-focused and solutions-oriented global organization. This is a testament to the strength of the Sigma-Aldrich brand and the accomplishments of our 9,000 employees worldwide.


“We believe this is a very positive outcome for our shareholders, who will receive a significant premium, and our employees, who will benefit from enhanced opportunities as part of a larger, more global organisation.”


combination of Merck KGaA, Darmstadt, Germany, and Sigma-Aldrich will secure stable growth and profitability in an industry that is driven by trends such as the globalization of research and manufacturing.”


He added: “What’s more, the combination gives us the possibility to invest even more in innovation going forward. We are delighted to make this compelling proposition to Sigma- Aldrich’s shareholders, who will obtain full and certain cash value for their shares.”


Rakesh Sachdev, president and CEO of Sigma-Aldrich, said, “We are excited to join forces with Merck KGaA, Darmstadt, Germany, a distinguished industry leader. This transaction is a clear validation of our success in transforming Sigma-


In the Laboratory & Academia business, together EMD Millipore and Sigma- Aldrich will offer their customers a complementary range of products across laboratory chemicals, biologics and reagents. In pharma and biopharma production, Sigma- Aldrich will complement EMD Millipore’s existing products and capabilities with additions along the entire value chain of drug production and validation.


Shaped over almost 350 years by a family of owners, Merck believes that the combination will afford new opportunities to employees at both companies. It plans to maintain a significant presence in St. Louis, and in Billerica, following completion of the transaction, as well as in important EMD Millipore sites such as Darmstadt and Molsheim, France.


Veeco’s ion beam technology reaches milestone VEECO INSTRUMENTS has announced


that its new OdysseyIon Beam Deposition(IBD) Upgrade for the NEXUS IBD-LDDSystem has repeatedly produced photomask blanks with zero deposition defects larger than 70 nm. This represents a significant milestone toward the manufacture of semiconductor devices with advanced extreme ultraviolet (EUV) lithography, according to the company.


EUV mask blank defects are, as a practical matter, impossible to repair and can render a semiconductor device useless. Because of this, mask blank defects have been a key obstacle toward high volume manufacturing.


“EUV lithography brings chipmakers the ability to manufacture higher performing


devices at lower cost compared to manufacturing methods which rely on multiple patterning steps,” said Ron Kool, senior VP of EUV product and service marketing at ASML, the Netherlands- based lithography systems company. “As ASML is making steady progress preparing the scanner and light source for industrial high volume manufacturing, the readiness of the EUV industry, including mask blanks, is critically important to our customers. Veeco’s dedication to the Odyssey upgrade program, done in coordination with customers, consortia, and other industry stakeholders, is a model for EUV infrastructure advancements.”


Veeco IBD technology leads the industry in high film quality, featuring extremely low particulate deposition and precise


16 www.compoundsemiconductor.net October 2014 Copyright Compound Semiconductor


control of optical properties for single or multi-layer processes. These technology features are required for defect-free, high volume EUV manufacturing. Currently, all of the leading EUV mask blank manufacturers use the Veeco NEXUS IBD-LDD system.


“Veeco is committed to working with our customers and industry partners to advance the EUV roadmap and increase the output of defect-free mask blanks,” said Jim Northup, Senior Vice President and General Manager of Veeco Advanced Deposition & Etch. “We have made significant investments in the Odyssey upgrade and consolidated our optical coating and ion beam resources in a single R&D site to ensure ongoing development of our industry-leading IBD technology.”


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76